http://orcid.org/0000-0002-6088-6603
Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kelly A. King & Carmen C. Brewer. (2018) Clinical trials, ototoxicity grading scales and the audiologist’s role in therapeutic decision making. International Journal of Audiology 57:sup4, pages S19-S28.
Read now
Read now
Angela C. Garinis, Alexandra Cornell, Gopal Allada, Kevin P. Fennelly, Ronald J. Maggiore & Dawn Konrad-Martin. (2018) Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology. International Journal of Audiology 57:sup4, pages S42-S47.
Read now
Read now
Articles from other publishers (34)
Katharine A. Fernandez, Angela Garinis, Kristin Knight, Dawn Konrad-Martin, Thais Morata, Gayla L. Poling, Kelly M. Reavis, Victoria A. Sanchez & Laura Dreisbach. (2023) What's New in Ototoxicity Management?. Perspectives of the ASHA Special Interest Groups, pages 1-11.
Crossref
Crossref
David S. Lee, Emma Y. Travis, Susan K. Wong, Cathryn Collopy, Katrina S. McClannahan, Amanda J. Ortmann, Jason T. Rich, Patrik Pipkorn, Sidharth V. Puram, Ryan S. Jackson, Randal C. Paniello, Douglas R. Adkins, Peter Oppelt, Wade L. Thorstad, Cameron C. Wick, Jose P. Zevallos & Angela L. Mazul. (2023) Audiologic Follow‐up in Patients With Head and Neck Cancer Treated With Cisplatin and Radiation. The Laryngoscope 133:11, pages 3161-3168.
Crossref
Crossref
Valeria Gambacorta, Eva Orzan, Mario Faralli, Mario Gullà, Ruggero Lapenna, Irene Baietta, Verena De Angelis & Giampietro Ricci. (2023) Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center. Audiology Research 13:5, pages 779-790.
Crossref
Crossref
Nisha A. Mohindra. (2023) Preventing, Monitoring, and Managing Ototoxicity Related to Cisplatin: Proactive Rather Than Reactive Approaches Are Needed. JCO Oncology Practice 19:5, pages 286-287.
Crossref
Crossref
Asmi Chattaraj, Masood Pasha Syed, Carissa A. Low & Taofeek K. Owonikoko. (2023) Cisplatin-Induced Ototoxicity: A Concise Review of the Burden, Prevention, and Interception Strategies. JCO Oncology Practice 19:5, pages 278-283.
Crossref
Crossref
Lucia Jane Stevenson, Leigh Biagio-de Jager, Marien Alet Graham & De Wet Swanepoel. (2023) Extended High-Frequency Audiometry for Ototoxicity Monitoring: A Longitudinal Evaluation of Drug-Resistant Tuberculosis Treatment. American Journal of Audiology 32:1, pages 70-80.
Crossref
Crossref
Dawn Konrad-Martin, Rachel Polaski, J. Riley DeBacker, Sarah M. Theodoroff, Angela Garinis, Cecilia Lacey, Kirsten Johansson, Rosemarie Mannino, Trisha Milnes, Michelle Hungerford & Khaya D. Clark. (2023) Audiologists’ perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey. Journal of Cancer Survivorship 17:1, pages 69-81.
Crossref
Crossref
Amy Custer. (2022) A Tale of Two Susceptibilities: Cisplatin Ototoxicity Variability in Similar Patients. Perspectives of the ASHA Special Interest Groups 7:6, pages 1782-1791.
Crossref
Crossref
Jessica Paken, Cyril D. Govender, Mershen Pillay & Vikash Sewram. (2022) Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting. BMC Health Services Research 22:1.
Crossref
Crossref
Victoria A. Sanchez, Michelle L. Arnold, David R. Moore, Odile Clavier & Harvey B. Abrams. (2022) Speech-in-noise testing: Innovative applications for pediatric patients, underrepresented populations, fitness for duty, clinical trials, and remote services. The Journal of the Acoustical Society of America 152:4, pages 2336-2356.
Crossref
Crossref
Stephanie E. Pearson, Charlotte Caimino, Maryam Shabbir & David M. Baguley. (2021) The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study. Journal of Cancer Survivorship 16:5, pages 976-987.
Crossref
Crossref
Christina R. Studts. (2022) Implementation Science: Increasing the Public Health Impact of Audiology Research. American Journal of Audiology 31:3S, pages 849-863.
Crossref
Crossref
Katerina Ehlert, Barbara Heinze, Marien A Graham & De Wet Swanepoel. (2022) Changes in vestibular and cochlear function following platinum-based chemotherapy: A preliminary report. Ear, Nose & Throat Journal, pages 014556132211150.
Crossref
Crossref
Samantha Kleindienst Robler, Laura Coco & Mark Krumm. (2022) Telehealth solutions for assessing auditory outcomes related to noise and ototoxic exposures in clinic and research. The Journal of the Acoustical Society of America 152:3, pages 1737-1754.
Crossref
Crossref
Odile H. Clavier, James A. Norris, David W. HinckleyJr.Jr., William Hal Martin, Shi Yuan Lee, Sigfrid D. Soli, Douglas S. Brungart, Jaclyn R. Schurman, Erik Larsen, Golbarg Mehraei & Tera M. Quigley. (2022) Reference equivalent threshold sound pressure levels for the Wireless Automated Hearing Test System. The Journal of the Acoustical Society of America 152:1, pages 601-608.
Crossref
Crossref
Colleen G. Le Prell, Carmen C. Brewer & Kathleen C. M. Campbell. (2022) The audiogram: Detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear. The Journal of the Acoustical Society of America 152:1, pages 470-490.
Crossref
Crossref
K Ehlert, B Heinze, M A Graham & D Swanepoel. (2022) Surveillance for ototoxicity in platinum-based chemotherapy using mobile health audiometry with extended high frequencies. The Journal of Laryngology & Otology, pages 1-7.
Crossref
Crossref
Melanie Lough & Christopher J. Plack. (2022) Extended high-frequency audiometry in research and clinical practice. The Journal of the Acoustical Society of America 151:3, pages 1944-1955.
Crossref
Crossref
Kristine Sonstrom Malowski, Lindsay H. Gollihugh, Heather Malyuk & Colleen G. Le Prell. (2022) Auditory changes following firearm noise exposure, a review. The Journal of the Acoustical Society of America 151:3, pages 1769-1791.
Crossref
Crossref
Katerina Ehlert, Barbara Heinze & De Wet Swanepoel. (2022) Ototoxicity monitoring in South African cancer facilities: A national survey. South African Journal of Communication Disorders 69:1.
Crossref
Crossref
Nazeera Peerbhay, Danielle R Munsamy, Hombisa P Dlamini, Fisokuhle Langa & Jessica Paken. (2022) The use of tele-audiology in ototoxicity monitoring: A scoping review. Journal of Telemedicine and Telecare, pages 1357633X2110682.
Crossref
Crossref
N. M. Santucci, B. Garber, R. Ivory, M. A. Kuhn, M. Stephen & D. Aizenberg. (2021) Insight into the current practice of ototoxicity monitoring during cisplatin therapy. Journal of Otolaryngology - Head & Neck Surgery 50:1.
Crossref
Crossref
Dawn Konrad-Martin, Keri O'Connell Bennett, Angela Garinis & Garnett P. McMillan. (2021) A Randomized Controlled Trial Using Automated Technology for Improving Ototoxicity Monitoring in VA Oncology Patients. American Journal of Audiology 30:3S, pages 870-886.
Crossref
Crossref
Angela C. Garinis, Gayla L. Poling, Ronald C. Rubenstein, Dawn Konrad-Martin, Timothy E. Hullar, David M. Baguley, Holly L. Burrows, Jennifer A. Chisholm, Amy Custer, Laura Dreisbach Hawe, Lisa L. Hunter, Theodore K. Marras, Candice E. Ortiz, Lucretia Petersen, Peter S. Steyger, Kevin Winthrop, Erika M. Zettner, Khaya Clark, Michelle Hungerford, Jay J. Vachhani & Carmen C. Brewer. (2021) Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis. American Journal of Audiology 30:3S, pages 800-809.
Crossref
Crossref
Shirley P HuangCameron J McKinzieCasey R Tak. (2021) Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose IV aminoglycosides. Journal of Managed Care & Specialty Pharmacy 27:2, pages 157-165.
Crossref
Crossref
Katharine A. Fernandez, Paul Allen, Maura Campbell, Brandi Page, Thomas Townes, Chuan-Ming Li, Hui Cheng, Jaylon Garrett, Marcia Mulquin, Anna Clements, Deborah Mulford, Candice Ortiz, Carmen Brewer, Judy R. Dubno, Shawn Newlands, Nicole C. Schmitt & Lisa L. Cunningham. (2021) Atorvastatin is associated with reduced cisplatin-induced hearing loss. Journal of Clinical Investigation 131:1.
Crossref
Crossref
Virginia Fancello, Stavros Hatzopoulos, Virginia Corazzi, Chiara Bianchini, Magdalena B Skarżyńska, Stefano Pelucchi, Piotr Henryk Skarżyński & Andrea Ciorba. (2021) SARS-CoV-2 (COVID-19) and audio-vestibular disorders. International Journal of Immunopathology and Pharmacology 35, pages 205873842110273.
Crossref
Crossref
Hinrich Staecker. (2021) Re-evaluating aminoglycoside ototoxicity. Journal of Cystic Fibrosis 20:1, pages 5.
Crossref
Crossref
Alaa Koleilat, Colin L. W. Driscoll, Lisa A. Schimmenti & Gayla L. Poling. (2020) Emerging Therapies and Approaches to Treat and Prevent Hearing Loss. Perspectives of the ASHA Special Interest Groups 5:5, pages 1147-1165.
Crossref
Crossref
Anitha Vijayasingam, Emily Frost, Julie Wilkins, Lise Gillen, Presanna Premachandra, Kate Mclaren, Desmond Gilmartin, Lorenzo Picinali, Alberto Vidal-Diez, Simone Borsci, Melody Zhifang Ni, Wai Y Tang, Deborah Morris-Rosendahl, Jonny Harcourt, Caroline Elston, N J Simmonds & Anand Shah. (2020) Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis. Thorax 75:8, pages 632-639.
Crossref
Crossref
Benjamin K. Gersten, Tracy S. Fitzgerald, Katharine A. Fernandez & Lisa L. Cunningham. (2020) Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents. Journal of the Association for Research in Otolaryngology 21:4, pages 303-321.
Crossref
Crossref
Dawn Konrad-Martin, Neela Swanson & Angela Garinis. (2019) A Guide to Coding and Billing for the Audiological Management of Patients Receiving Ototoxic Medical Treatments. Perspectives of the ASHA Special Interest Groups 4:5, pages 936-946.
Crossref
Crossref
Gayla L. Poling, Brittany Vlosich & Laura E. Dreisbach. (2019) Emerging Distortion Product Otoacoustic Emission Techniques to Identify Preclinical Warning Signs of Basal Cochlear Dysfunction Due to Ototoxicity. Applied Sciences 9:15, pages 3132.
Crossref
Crossref
Stephanie E Pearson, John Taylor, Derek J Hoare, Poulam Patel & David M Baguley. (2019) Exploring the Experiences of Cancer Patients With Chemotherapy-Induced Ototoxicity: Qualitative Study Using Online Health Care Forums. JMIR Cancer 5:1, pages e10883.
Crossref
Crossref